Nicholas Hobart-Porter, Michal Stein, Naveh Toh, Novinyo Amega, Huy-Binh Nguyen, & James Linakis. (2021). Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure. Taylor & Francis Group.
Chicago Style (17th ed.) CitationNicholas Hobart-Porter, Michal Stein, Naveh Toh, Novinyo Amega, Huy-Binh Nguyen, and James Linakis. Safety and Efficacy of Rabies Immunoglobulin in Pediatric Patients with Suspected Exposure. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationNicholas Hobart-Porter, et al. Safety and Efficacy of Rabies Immunoglobulin in Pediatric Patients with Suspected Exposure. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.